Benchmarking: Clinical Trials

20 trials of Benchmarking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 4 unknown, 2 active not recruiting, 2 terminated. 7 Phase 2, 4 Not applicable, 4 Phase 4, 3 Phase 1, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Active not recruiting 1, Terminated 1
Not applicable4Completed 3, Unknown 1
Phase 44Unknown 2, Active not recruiting 1, Completed 1
Phase 13Completed 3
Early Phase 12Terminated 1, Unknown 1
Phase 31Completed 1

Follow Benchmarking: new trials by email Literature Review of Benchmarking trials Research Report on Benchmarking

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age
Longidaza, Metronidazole 500 mg - Bacterial Vaginosis
Phase 4UnknownI.M. Sechenov First Moscow State Medical University1002024-06-012025-04-09
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
Biopsy, Fecal Microbiota Transplantation, Fecal Microbiota Transplantation Capsule - Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma
Phase 2Active not recruitingM.D. Anderson Cancer Center152021-02-222026-06-12
PROJECT PREVENT: Metronidazole Antibiotic Per Vagina Before Hysterectomy: Is Additional Antibiotic Prophylaxis Beneficial?
Metronidazole Vaginal - Post-Op Infection
Phase 4Active not recruitingNew York Medical College1362020-07-152023-05-17
Post-Endoscopic Infection Rate Notifications to Improve the Delivery of Care
Option 1: National comparison, Option 2: National comparison with benchmarking - Infection
Not applicableCompletedJohns Hopkins University3032019-08-072023-06-23
Prevention of Dry Socket by Means of Single Preoperative Antibiotics Compared to Conventional Therapy
Amoxicillin 500 Mg, metronidazole 400mg, metronidazol 400mg and amoxicillin 500mg - Dry Socket
Phase 2CompletedDow University of Health Sciences2252018-10-012019-06-20
Peritonsillar Abscess: Aspiration Versus Tonsillectomy a Chaud
Aspiration, Tonsillectomy a chaud, Penicillin V + metronidazol (Penicillin allergy: Clindamycin alone) - Peritonsillar Abscess
Not applicableUnknownOdense University Hospital1282017-11-102017-11-09
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Polyethylene Glycol, Neomycin, Metronidazole Hydrochloride - Colorectal Neoplasms, Diverticulitis
Early Phase 1UnknownThomas Jefferson University2242016-09-012018-08-22
Efficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
RIFAXIMIN VAGINAL TABLET 25 MG, RIFAXIMIN VAGINAL TABLET 100 MG, PLACEBO VAGINAL TABLET - BACTERIAL VAGINOSIS
Phase 2TerminatedAlfasigma S.p.A.3922015-04-012016-10-10
Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis
probiotic yoghurt, chemically acidified milk, Arilin - Bacterial Vaginosis
Not applicableCompletedClinical Research Center Kiel GmbH362015-02-012016-11-17
Impact of Oral Antibiotic Treatment on C. Difficile
Fidaxomicin, Metronidazole, Vancomycin - C. Difficile, Diarrhea
Phase 4CompletedDuke University332014-06-102019-10-02
Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
Metronidazole benzoate, Flagyl 125 mg/5 ml oral suspension, Flagyl 400 mg Tablets - Bacterial Infections
Phase 1CompletedVerisfield UK Ltd. Greek Branch62014-06-012014-08-01
Patients Response to Early Switch To Oral:Osteomyelitis Study
oral antibiotics, intravenous antibiotics - Osteomyelitis
Early Phase 1TerminatedJulio Ramirez112014-03-062021-04-06
Conservative Treatment of Acute Appendicitis in Children
Appendectomy, Conservative, non-surgical treatment - Appendicitis, Child
Not applicableCompletedKarolinska University Hospital512012-02-012012-10-17
Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients
BFH772 1% ointment, Vehicle ointment, Noritate® 1% cream - Erythemato-telangiectatic Rosacea
Phase 2CompletedNovartis Pharmaceuticals362011-09-012021-02-21
Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures
Metronidazole, Cefuroxime, Amoxicillin (+ clavulanic acid) and Fluconazole, Placebo - Acute Appendicitis, Perforated Gastroduodenal Ulcer
Phase 3CompletedThe Faculty Hospital Na Bulovce1872008-07-012012-02-08
The Treatment of Periodontal Diseases
Metronidazol - Digestive System Disorders, Adverse Effects
Phase 4UnknownUniversity of Oslo1842008-01-012013-11-20
Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer
Sargramostim (GM-CSF, Leukine), Flutamide (Eulexin), PROSTVAC-F/ TRICOM - Prostate Cancer
Phase 2CompletedNational Cancer Institute (NCI)642007-02-232018-11-29
Study of Conservative Versus Surgical Treatment of Appendicitis
cefotaxim and metronidazol - Appendicitis
Phase 2CompletedGöteborg University3602006-05-012009-04-21
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
Metronidazole - Bacterial Vaginosis
Phase 1 / Phase 2CompletedTeva Pharmaceuticals USA5792002-01-012024-08-19
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects
Metronidazole - Healthy
Phase 1CompletedTeva Pharmaceuticals USA382001-11-012010-06-29

Conditions studied

Vaginosis, Bacterial (4)  ·  Appendicitis (3)  ·  Colorectal Neoplasms (2)  ·  Surgical Wound Infection (2)  ·  Bacterial Infections (1)  ·  Diarrhea (1)  ·  Digestive System Diseases (1)  ·  Diverticulitis (1)  ·  Dry Socket (1)  ·  Enterocolitis (1)  ·  Infections (1)  ·  Inflammatory Bowel Diseases (1)  ·  Osteomyelitis (1)  ·  Periodontitis (1)  ·  Peritonsillar Abscess (1)

Sponsors

Teva Pharmaceuticals USA (2)  ·  Alfasigma S.p.A. (1)  ·  Clinical Research Center Kiel GmbH (1)  ·  Dow University of Health Sciences (1)  ·  Duke University (1)  ·  Göteborg University (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  Johns Hopkins University (1)  ·  Julio Ramirez (1)  ·  Karolinska University Hospital (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  New York Medical College (1)  ·  Novartis Pharmaceuticals (1)  ·  Odense University Hospital (1)

Countries

United States (11)  ·  Sweden (2)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Jordan (1)  ·  Norway (1)  ·  Pakistan (1)  ·  Russia (1)

Top investigators

Abdullah Hiyari, MD (1)  ·  Benjamin Phillips, MD (1)  ·  Christiane Laue, Dr. med. (1)  ·  Daniel J Sexton, MD (1)  ·  David Seligson, MD (1)  ·  Hans R Preus, PhD (1)  ·  Jan F Svensson, MD (1)  ·  Julio Ramirez, MD (1)  ·  Kent Lundholm (1)  ·  Kseniya Rossolovskaya (1)  ·  Leonid Spivak, MD,Prof. (1)  ·  Michael J Overman (1)  ·  Naji Najib, B.Sc. Pharm (1)  ·  Ondrej Ryska, MD (1)

Results publications

PMID 15276398, PMID 15840453, PMID 19358184, PMID 19588358, PMID 22530208, PMID 25072441, PMID 25981528, PMID 27767387, PMID 28796888, PMID 31603245, PMID 31800496, PMID 34017999, PMID 34790237, PMID 36748942, PMID 37134294, PMID 38596254, PMID 4902833, PMID 8948280

NIH funding

P50CA221707 (1)